|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Research and product development | |||
| Marketing and sales | |||
| General and administrative | |||
| Impairment charge | |||
| Total operating expenses | |||
| Operating income/(loss) | |||
| Interest expense | |||
| Other income, net | |||
| Income/(loss) before provision for income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Less: accretion of redeemable convertible preferred stock to redemption value | |||
| Less: deemed dividends upon repurchase of redeemable convertible preferred stock | |||
| Less: declared dividends to preferred shareholders | |||
| Net loss attributable to Class A, Class B, Class C common stockholders, basic | |||
| Net loss attributable to Class A, Class B, Class C common stockholders, dilutive | |||
| Net loss per share attributable to Class A, Class B and Class C common stockholders, basic (in dollars per share) | |||
| Net loss per share attributable to Class A, Class B and Class C common stockholders, dilutive (in dollars per share) | |||
| Weighted-average shares used in computing net loss per share attributable to Class A, Class B and Class C common stockholders, basic (in shares) | |||
| Weighted-average shares used in computing net loss per share attributable to Class A, Class B and Class C common stockholders, dilutive (in shares) |
Loading...
